Abstract
Urothelial cancer (UC) is the most common malignancy involving the urinary system. The objective of IMPACT UC was to assess Tx patterns and clinical outcomes among Medicare Fee-for-Service (FFS) pts with mUC treated with chemotherapy or immuno-oncology monotherapy (IO-mono) in the 1L setting.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
